ArticleIBRO neuroscience reports2026

A novel therapeutic regimen based on the constrained-disorder principles may improve the response to dimethyl fumarate in multiple sclerosis: Findings from an exploratory feasibility open-label clinical trial.

Hillel Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.